Company research
HEALTHY EXTRACTS INC.
CIK 1630176Updated Sep 26, 2026
SecurityHYEX · OTC · equity
Name history
HEALTHLY EXTRACTS INC. · through Mar 11, 2021GREY CLOAK TECH INC. · through Feb 19, 2021
HYEX price & chart
Loading TradingView…
OTC:HYEX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
10-Q filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Show 5 more recent filings
Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Unregistered Sales of Equity Securities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 1.01, 2.01, 3.02, 5.02, 9.01
10-Q filing
10-K filing
NT 10-K filing
10-Q filing
Financials
FY 2025 · USDSource
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 27,824,664Source | 2,377,973Source | 2,635,014Source | 2,781,118Source |
| GoodwillUSD | 21,123,922Source | 193,260Source | 193,260Source | 193,260Source |
| Current assets: | ||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 187,750Source | 11,003Source | 30,440Source | 105,794Source |
| Inventory, NetUSD | 843,357Source | 1,361,216Source | 1,626,283Source | 1,819,128Source |
| Assets, CurrentUSD | 1,327,317Source | 1,659,387Source | 1,899,678Source | 1,990,572Source |
| Operating Lease, Right-of-Use AssetUSD | 0Source | 8,984Source | 71,583Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 3,795,099Source | — | — | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 368,413Source | 354,532Source | 354,492Source | 345,172Source |
| Additional Paid in CapitalUSD | 43,788,013Source | 19,301,589Source | 18,999,770Source | 17,459,899Source |
| Retained Earnings (Accumulated Deficit)USD | -20,121,462Source | -19,240,344Source | -18,399,673Source | -15,926,742Source |
| Stockholders' Equity Attributable to ParentUSD | 24,029,564Source | 410,377Source | 954,590Source | 1,878,330Source |
| Liabilities and EquityUSD | 27,824,664Source | 2,377,973Source | 2,635,014Source | 2,781,118Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 1,688,169Source | 1,967,596Source | 1,680,424Source | 902,788Source |
| Operating Lease, Liability, CurrentUSD | 171,930Source | 9,222Source | 65,229Source | — |
| Accounts Payable, CurrentUSD | 108,496Source | 52,248Source | 116,842Source | 91,316Source |
| Operating Lease, Liability, NoncurrentUSD | 344,265Source | 0Source | 9,222Source | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 613,645Source | 248,609Source | 215,069Source | 94,554Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -881,119Source | -840,671Source | -2,472,931Source | -983,121Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | 0Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 139,703Source | -19,437Source | -75,353Source | -27,547Source |
| Increase (Decrease) in InventoriesUSD | -546,161Source | -265,067Source | -192,845Source | -138,838Source |
| Increase (Decrease) in Accounts PayableUSD | 24,503Source | -64,595Source | — | 54,048Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 165,520Source | 281,968Source | -415,749Source | -334,964Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 56,301Source | 0Source | 0Source | -7,987Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | 0Source | 7,987Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -186,906Source | -189,389Source | 369,539Source | 186,504Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 34,915Source | 92,579Source | -46,210Source | -156,447Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 146,935Source | 112,020Source | 19,441Source | 65,651Source |
| Additional Financial Items | ||||
| Gain (Loss) on Disposition of Other AssetsUSD | — | — | 0Source | 2,643Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | 38,172Source | 38,172Source | 0Source |
| Gain (Loss) on Disposition of Assets for Financial Service OperationsUSD | — | — | — | -2,643Source |
| General and Administrative ExpenseUSD | 3,366,341Source | 2,094,469Source | 3,865,654Source | 2,283,107Source |
| GoodwillUSD | 21,123,922Source | 193,260Source | 193,260Source | 193,260Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 0Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Inventory Write-downUSD | — | — | — | 96,811Source |
| Net Income (Loss) Attributable to ParentUSD | -881,119Source | -840,671Source | -2,472,931Source | -983,121Source |
| Operating ExpensesUSD | 3,366,341Source | 2,094,469Source | 3,865,654Source | 2,283,107Source |
| Other Nonoperating Income (Expense)USD | 62,731Source | -657,522Source | -229,088Source | -71,531Source |
| Proceeds from Issuance of Common StockUSD | — | 0Source | -90,000Source | -11,386Source |
| Unrealized Gain (Loss) on DerivativesUSD | 273,010Source | -471,270Source | -52,140Source | -9,484Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 4,511,997Source | 3,113,279Source | 2,485,866Source | 2,251,469Source |
| Cost of RevenueUSD | 2,089,506Source | 1,201,959Source | 864,055Source | 783,141Source |
| Other Nonoperating Income (Expense)USD | 62,731Source | -657,522Source | -229,088Source | -71,531Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | — |
| Net Income (Loss) Attributable to ParentUSD | -881,119Source | -840,671Source | -2,472,931Source | -983,121Source |
| Additional Financial Items | ||||
| Business Combination, Acquisition Related CostsUSD | — | — | — | 0Source |
| General and Administrative ExpenseUSD | 3,366,341Source | 2,094,469Source | 3,865,654Source | 2,283,107Source |
| Gross ProfitUSD | 2,422,491Source | 1,911,320Source | 1,621,810Source | 1,371,517Source |
| Interest Income (Expense), NetUSD | -210,279Source | -186,252Source | -176,948Source | -64,690Source |
| Operating ExpensesUSD | 3,366,341Source | 2,094,469Source | 3,865,654Source | 2,283,107Source |